A new study published in the International Journal of Chronic Obstructive Pulmonary Disease showed a non-linear association ...

Increasing evidence indicates that aging contributes to the risk for chronic respiratory diseases, but the impact of ...

Upstream Bio Inc. (NASDAQ:UPB) is one of the best IPO stocks to buy according to Wall Street analysts. Earlier on July 8, ...

AstraZeneca has completed a Phase 3 clinical study titled ‘RESOLUTE,’ aimed at evaluating the efficacy and safety of Benralizumab in patients with moderate to very severe Chronic Obstructive Pulmonary ...

Treatment Devices Market is set to grow at a CAGR of 6.35% from 2025 to 2032. This surge is driven by rising COPD prevalence due to factors like tobacco smoking and air pollution, increased awareness, ...

Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder characterised by persistent airflow limitation and chronic inflammation. Beyond its primary pulmonary ...